The human T cell lymphotropic virus type 2 (HTLV-2) is found mainly in Amerindians and in intravenous drug users (IDUs) from urban areas of the United States, Europe, and Latin America. Worldwide, HTLV-2a and HTLV-2b subtypes are the most prevalent. Phylogenetic analysis of HTLV-2 isolates from Brazil showed the HTLV-2a subtype, variant -2c, which spread from Indians to the general population and IDUs. The present study searched for the types of HTLV-2 that predominate among HIV-1-coinfected patients from southern and southeastern Brazil. Molecular characterization of the LTR, env, and tax regions of 38 isolates confirmed the HTLV-2c variant in 37 patients, and one HTLV-2b in a patient from Paraguay. Phylogenetic analysis of sequences showed different clades of HTLV-2 associated with risk factors and geographic region. These clades could represent different routes of virus transmission and/or little diverse evolutionary rates of virus. Taking into account the results obtained in the present study and the lack of the prototypic North American HTLV-2a strain and HTLV-2b subtypes commonly detected among HIV-coinfected individuals worldwide, we could speculate on the introduction of Brazilian HTLV-2 strains in such populations before the introduction of HIV.
Get full access to this article
View all access options for this article.
References
1.
MurphyEL, MahieuxR, De ThéGet al.Molecular epidemiology of HTLV-II among United States blood donors and intravenous drug user: An age-cohort effect for HTLV-II RFLP type a. Virology, 1998; 242:425–434.
2.
ZellaD, MoriL, FerranteP, CasoliC, MagnaniG, AchilliG, CattaneoE, LoriF, BertazzoniU. HTLV-II infection in Italian drug users. Lancet, 1990; 335:575–576.
3.
TaylorGP. The human T cell lymphotropic viruses. Principles and Practice of Clinical Virology, 5thZuckermanAJ, BanatvalaJE, PattisonJR, GriffithsPD, SchoubBD. John Wiley & Sons Ltd: Piscataway, NJ, 2004; 759–777.
4.
Catalan-SoaresB, Carneiro-ProiettiAB, ProiettiFA. Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban areas in Brazil. Cadern Saúde Públ (Rio de J), 2005; 21:926–931.
5.
GabbaiAA, BordiniJO, Vieira-FilhoJPBet al.Selectivity of human T lymphotropic vírus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg, 1993; 49:664–671.
6.
EtzelA, ShibataGY, RozmanM, JorgeMLSG, DamasCD, SeguradoAAC. HTLV-1 and HTLV-2 infections in HIV infected individuals from Santos, Brazil: Seroprevalence and risk factors. J Acquir Immune Defic Syndr, 2001; 26:185–190.
7.
IshakR, VallinotoACR, AzevedoVN, IshakMQ. Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil. Cad Saúde púb (Rio de J), 2003; 19:901–914.
8.
Menna-BarretoM, BenderAL, BonattoSLet al.Human T cell lymphotropic virus type II in Guaraní Indians, Southern Brazil. Cad Saúde Púb (Rio de J), 2005; 21:1947–1951.
9.
MorimotoHK, Caterino-de-AraujoA, MorimotoAAet al.Seroprevalence and risk factors for human T-cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus (HIV)-infected patients attending AIDS Referral Center Health Units in Londrina and other communities in Paraná, Brazil. AIDS Res Hum Retroviruses, 2005; 21:256–262.
10.
OliveiraEH, Oliveira-FilhoAB, SouzaLAet al.Human T-cell lymphotropic virus in patients infected with HIV-1: Molecular epidemiology and risk factors for transmission in Piauí, North-eastern Brazil. Curr HIV Res, 2012; 10:700–707.
11.
LemeyP, PybusOG, Van DoorenS, VandammeAM. A Bayesian statistical analysis of human T-cell lymphotropic virus evolutionary rates. Infect Genet Evol, 2005; 5:291–298.
12.
BanghamCRM, OsameM. Cellular immune response to HTLV-1. Oncogene, 2005; 24:6035–6046.
13.
EirakuN, NovoaP, FerreiraMCet al.Identification and characterization of new and distinct molecular subtype of human T-cell lymphotropic vírus type 2. J Virol, 1996; 70:1481–1492.
14.
FeuerG, GreenPL. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene, 2005; 24:5996–6004.
15.
CovasDM, KashimaS. Complete nucleotide sequences of the genomes of two Brazilian specimens of human T lymphotropic virus type 2 (HTLV-2)AIDS Res Hum Retroviruses, 2003; 19:689–697.
16.
IshakR, HarringtonWJ, AzevedoVNet al.Identification of human T-cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses, 1995; 11:813–821.
17.
VandammeAM, SalemiM, Van BrusselMet al.African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies. J Virol, 1998; 72:4327–4340.
18.
SlatteryJP, FranchiniG, GessainA. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res, 1999; 9:525–540.
19.
AlcantaraLCJ, ShindoN, Van DorenSet al.Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Amerindians and European/North American IDUs. AIDS Res Hum Retroviruses, 2003; 19:519–523.
20.
RennerJDP, LaurinoJP, Menna-BarretoM, SchmittVM. Molecular evidence of HTLV-II subtype B among an urban population living in South Brazil. AIDS Res Hum Retroviruses, 2006; 22:301–306.
21.
NovoaP, Penalva de OliveiraAC, Posada-VergaraMP, DuarteAJS, CassebJ. Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: Evidence of multiple subtypes circulation. J Med Virol, 2007; 79:182–187.
22.
MagriMC, MorimotoHK, BrígidoLFM, RodriguesR, Caterino-de-AraujoA. Long terminal repeat sequence analysis of HTLV-2 molecular variants identified in Southern Brazil. AIDS Res Hum Retroviruses, 2010; 26:1327–1331.
23.
EganJF, O'LearyB, LewisMJet al.High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses, 1999; 15:699–705.
24.
ShindoN, AlcantaraLC, Van DoorenSet al.Human retroviruses (HIV and HTLV) in Brazilian Indians: Seroepidemiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res Hum Retroviruses, 2002; 18:71–77.
25.
LeeH, IdlerKB, SwansonPet al.Complete nucleotide sequence of HTLV-II isolate NRA: Comparison of envelope sequence variation of HTLV_II isolates from U.S. blood donors and U.S. and Italian IV drug users. Virology, 1993; 196:57–69.
26.
SalemiM, VandammeAM, GradozziCet al.Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J Mol Evol, 1998; 46:602–611.
27.
LewisMJ, SheehyN, SalemiM, VanDammeAM, HallWW. Comparison of CREB- and NK-B-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) Tax proteins. Virology, 2002; 295:182–189.
28.
SalemiM, LewisM, EganJF, HallWW, DesmyterJ, VandammeA. Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA, 1999; 96:13253–13258.
29.
OlahI, FukumoriLMI, SmidJet al.Neither molecular diversity of the envelope, immunosuppression status, nor proviral load causes indeterminate HTLV Western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals. J Med Virol, 2010; 82:837–842.
30.
WattelE, VartanianJP, PannetierC, Wain-HobsonS. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol, 1995; 69:2863–2868.
31.
LemeyP, Kosakovsky PondSL, DrummondAJet al.Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol, 2007; 3,2:e29.
32.
HahnBH, ShawGM, TaylorMEet al.Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science, 1986; 232:1548–1553.
33.
BiggarRJ, TaylorME, NeelJVet al.Genetic variants or human T lymphotropic virus type II in American Indian groups. Virology, 1996; 216:165–173.
34.
SwitzerWM, BlackFL, PieniazekD, BiggarRJ, LalRB, HeneineW. Endemicity and phylogeny of the human T cell lymphotropic vírus type II subtype A from the Kayapo Indians of Brazil: Evidence for limited regional dissemination. AIDS Res Human Retroviruses, 1996; 12:635–640.
35.
MauclèreP, AfonsoPV, MeertensLet al.HTLV-2B strains, similar to those found in several Amerindian tribes, are endemic in central African Bakola pygmies. J Infect Dis, 2011; 203:1316–1323.
36.
SuzukiY, GojoboriT. The origin and evolution of the human T-cell lymphotropic virus type I and II. Virus Genes, 1998; 16:69–84.
37.
SalemiM, VandammeAM, DesmyterJ, CasoliC, BertazzoniU. The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy. Gene, 1999; 234:11–21.
38.
AbadM, DrondaF, DominguezE, MorenoS, VallejoA. HTLV-2b among HIV type 1-coinfected injecting drug users in Spain. AIDS Res Hum Retroviruses, 2011; 27:579–583.
39.
SalemiM, CattaneoE, CasoliC, BertazzoniU. Identification of IIa and IIb molecular subtypes of human T-cell lymphotropic virus type II among Italian injecting drug users. J Acquir Immune Defic Syndr, 1995; 8:516–520.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
